Loading…
← Back to schedule
Startup Pitch Presentations. Drug Development & Delivery
Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room
Each company will be given a six-minute spotlight to unveil investment opportunities in drug development and delivery—six minutes to ignite interest and sketch the future of medicine.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

  • Vaxdyn – Juan José Infante Viñolo, CEO
  • FatrixGel  – Pablo Sánchez-Rey Chiapasco, CEO & Founder
  • Flavii Therapeutics  – Ariadna Boloix Amenós & Ainia Bellver , CEO & CSO & Co-founders
  • Gate2brain – Mertixell Teixidó Turà, CEO & CSO
  • i+Med S.coop –  Andrea Zapater Matute, R&D Business Developer
  • Molefy Pharma - Tania Ortuño, Head of Operations
  • Nanogrow Biotech – Nicolás Galmarini Galmarini, CEO & Co-founder
  • Nostrum Biodiscovery –Marie-Eve Beaulieu, General Manager
  • Olavide Neuron STX S.L. (ONESTX) – Ángel Cebolla Ramírez, CEO
  • Ploid AI Biotech - Adolfo Gastalver, Co-Founder & CEO
  • Resistia – Ignacio Massone, CEO & Co-founder

Speakers
avatar for Juan José Infante Viñolo

Juan José Infante Viñolo

CEO, Vaxdyn
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →
avatar for Pablo Sanchez-rey

Pablo Sanchez-rey

CEO & Founder, FatrixGel
Biologist and biotechnologist with a PhD in Biological Sciences and over 10 years of experience in the startup ecosystem. Former COO of a Fermentation Biotech, leading operations, strategic execution, and stakeholder relations. Currently CEO and founder of Fatrix Biotech, a biomaterial... Read More →
avatar for Ariadna Boloix Amenós

Ariadna Boloix Amenós

CEO & Co-founder, Flavii Therapeutics
Dr. Ariadna Boloix Amenós is CEO & Co-founder of Flavii Therapeutics S.L., leading corporate strategy and business development. She holds a PhD in Biochemistry and Biomedicine (UAB) and a Pharmacy degree (UB). Her research at the Vall d’Hebron Research Institute and Institute of Materials Science of Barcel... Read More →
avatar for Meritxell Teixidó Turà

Meritxell Teixidó Turà

Ceo & Cso, Gate2brain
Meritxell Teixidó holds a PhD in Organic Chemistry from the University of Barcelona and an eMBA from UOC. She spent more than 15 years at IRB Barcelona leading research on peptides capable of crossing biological barriers, co-supervising 10 PhDs, publishing over 50 scientific articles... Read More →
avatar for Andrea Zapater Matute

Andrea Zapater Matute

R&D Business Developer, i+Med S.coop
Andrea Zapater, PhD, is an R&D Business Development Manager at i+Med, focused on advanced biomaterials and drug delivery technologies for innovative therapeutic applications. She holds a PhD in Personalized Medicine and has experience in biotechnology, translational research, and... Read More →
avatar for Tania Ortuño

Tania Ortuño

Head of Operations, Molefy Pharma SL
Tania Ortuño is a biologist and doctor in Neuroscience with extensive experience combining scientific R&D with business development skills in innovation-driven environments. Her career spans neuroscience research and biotech operations, giving her a multidisciplinary profile at the... Read More →
avatar for Nicolás Galmarini

Nicolás Galmarini

CEO & Co-founder, Nanogrow Biotech
Economist and MBA with over 20 years in the pharmaceutical industry and a proven track record in establishing businesses across Latin America. Holds a BA in Economics from UdelaR and an MBA from Universidad Austral (Argentina). His extensive experience and entrepreneurial mindset... Read More →
avatar for Marie-eve Beaulieu

Marie-eve Beaulieu

General Manager, Nostrum Biodiscovery
Marie-Eve Beaulieu, PhD is General Manager of Nostrum Biodiscovery, a Barcelona- and Boston-based computational drug discovery technology company developing physics-based AI platforms for therapeutic design. She brings over 15 years of experience spanning drug discovery and executive leadership in biotech. Pr... Read More →
avatar for Angel Cebolla Ramírez

Angel Cebolla Ramírez

CEO, Olavide Neuron STX S.L. (ONESTX)
Dr. Ángel Cebolla is a scientist and serial bioentrepreneur with more than 25 years of experience translating academic research into profitable biotech solutions. After founding Biomedal and leading its world-class rapid food diagnostics division to a successful exit with the US... Read More →
avatar for Adolfo Gastalver

Adolfo Gastalver

Co-Founder & CEO, Ploid AI Biotech
Co-Founder & CEO of Ploid AI. Computer and electrical engineer specialized in AI, with two Master's degrees and a PhD candidacy in electrical engineering. Former AI researcher at CSIC-IIIA, with startup and consulting experience at Ingelectus and BCG.
avatar for Ignacio Massone

Ignacio Massone

CEO & Co-founder, Resistia
Former Big Pharma leader with a proven track record in business development and product launches. Currently Co-founder and CEO of Resistia, a deep-tech startup developing microbiome-derived therapies that restore the efficacy of existing antibiotics against resistant infections.

... Read More →
Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room
  Startup pitch presentations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share

Get help with the event

Contact event planner Event login
View support guides Find upcoming events
Create an event you'd love to attend!
Explore why organizers choose Sched • Success stories
Event App • Event scheduling • Event registration • Event ticketing • Sched forms • Call for papers • Badges • Conferences
© 2026. SCHED LLC - All rights reserved - Helping events since 2008
Event Planning Software • Privacy • Terms
Share Modal

Share this link via

Or copy link